Article Information
History
- June 3, 2021.
Article Versions
- You are currently viewing Version 1 of this article (June 3, 2021 - 10:30).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Chansavath Phetsouphanh1,*,&,
- David Darley2,*,
- Anette Howe1,
- C. Mee Ling Munier1,
- Sheila K Patel3,
- Jenifer A Juno4,
- Louise M Burrell3,
- Stephen J Kent4,5,
- Gregory J Dore1,2,
- Anthony D Kelleher1,2,†& and
- Gail Matthews1,2,†&
- 1The Kirby institute, University of New South Wales, NSW 2033, Australia
- 2St Vincent’s Hospital, Darlinghurst, NSW 2010, Australia
- 3Department of Medicine, Austin Health, University of Melbourne, Victoria 3084, Australia
- 4Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Victoria 3000, Australia
- 5Melbourne Sexual health centre, Infectious Diseases Department, Alfred health, central Clinical School, Monash University, Melbourne, Victoria 3004, Australia
- ↵&Correspondence Dr Chansavath Phetsouphanh, cphetsouphanh{at}kirby.unsw.edu.au, Prof. Anthony Kelleher, akelleher{at}kirby.unsw.edu.au, Prof. Gail Matthews, gmatthews{at}kirby.unsw.edu.au
↵*,† These authors contributed equally
Posted June 03, 2021.
Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection
